These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34246985)

  • 21. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of NQO1 status as a selective biomarker for oesophageal squamous cell carcinomas with greater sensitivity to 17-AAG.
    Hadley KE; Hendricks DT
    BMC Cancer; 2014 May; 14():334. PubMed ID: 24886060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors.
    Siegel D; Franklin WA; Ross D
    Clin Cancer Res; 1998 Sep; 4(9):2065-70. PubMed ID: 9748120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical Features of Epithelial-Mesenchymal Transition in Feline Oral Squamous Cell Carcinoma.
    Harris K; Gelberg HB; Kiupel M; Helfand SC
    Vet Pathol; 2019 Nov; 56(6):826-839. PubMed ID: 31331247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of mPGES1 and p16 in feline and human oral squamous cell carcinoma: A comparative oncology approach.
    Nasry WHS; Jones K; Rodriguez-Lecompte JC; Tesch M; Martin CK
    Vet Comp Oncol; 2024 Jun; 22(2):204-216. PubMed ID: 38378135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of the GSTP1 and NQO1 polymorphisms and head and neck squamous cell carcinoma risk.
    Cho CG; Lee SK; Nam SY; Lee MS; Lee SW; Choi EK; Park HJ; Kim SY
    J Korean Med Sci; 2006 Dec; 21(6):1075-9. PubMed ID: 17179690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical synthesis and biological evaluation of a NAD(P)H:quinone oxidoreductase-1 targeted tripartite quinone drug delivery system.
    Volpato M; Abou-Zeid N; Tanner RW; Glassbrook LT; Taylor J; Stratford I; Loadman PM; Jaffar M; Phillips RM
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3122-30. PubMed ID: 18089707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aerobic Cytotoxicity of Aromatic
    Nemeikaitė-Čėnienė A; Šarlauskas J; Misevičienė L; Marozienė A; Jonušienė V; Lesanavičius M; Čėnas N
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma.
    Cabello CM; Lamore SD; Bair WB; Davis AL; Azimian SM; Wondrak GT
    Free Radic Res; 2011 Mar; 45(3):276-92. PubMed ID: 21034357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1.
    Dehn DL; Winski SL; Ross D
    Clin Cancer Res; 2004 May; 10(9):3147-55. PubMed ID: 15131056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological inhibitors of NAD(P)H quinone oxidoreductase, NQO1: structure/activity relationships and functional activity in tumour cells.
    Nolan KA; Scott KA; Barnes J; Doncaster J; Whitehead RC; Stratford IJ
    Biochem Pharmacol; 2010 Oct; 80(7):977-81. PubMed ID: 20599803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NAD(P)H:quinone oxidoreductase 1 (NQO1) localizes to the mitotic spindle in human cells.
    Siegel D; Kepa JK; Ross D
    PLoS One; 2012; 7(9):e44861. PubMed ID: 22984577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the unfolded protein response in head and neck and oral cavity cancers.
    Cole DW; Svider PF; Shenouda KG; Lee PB; Yoo NG; McLeod TM; Mutchnick SA; Yoo GH; Kaufman RJ; Callaghan MU; Fribley AM
    Exp Cell Res; 2019 Sep; 382(1):111386. PubMed ID: 31075256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of NAD(P)H:quinone oxidoreductase 1 (NQO1) and genomic gain of the NQO1 locus modulates breast cancer cell sensitivity to quinones.
    Glorieux C; Sandoval JM; Dejeans N; Ameye G; Poirel HA; Verrax J; Calderon PB
    Life Sci; 2016 Jan; 145():57-65. PubMed ID: 26687450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of Dual Stimuli-Responsive Platinum(IV) Hybrids with NQO1 Targeting Ability and Overcoming Cisplatin Resistance.
    Fang L; Qin X; Zhao J; Gou S
    Inorg Chem; 2019 Feb; 58(3):2191-2200. PubMed ID: 30657321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal models of head and neck squamous cell carcinoma.
    Supsavhad W; Dirksen WP; Martin CK; Rosol TJ
    Vet J; 2016 Apr; 210():7-16. PubMed ID: 26965084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmented Concentration of Isopentyl-Deoxynyboquinone in Tumors Selectively Kills NAD(P)H Quinone Oxidoreductase 1-Positive Cancer Cells through Programmed Necrotic and Apoptotic Mechanisms.
    Wang J; Su X; Jiang L; Boudreau MW; Chatkewitz LE; Kilgore JA; Zahid KR; Williams NS; Chen Y; Liu S; Hergenrother PJ; Huang X
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of oral brushing as a non-invasive technique for the identification of feline oral squamous cell carcinoma by DNA methylation and TP53 mutation analysis.
    Renzi A; Morandi L; Bellei E; Marconato L; Rigillo A; Aralla M; Lenzi J; Bettini G; Tinto D; Sabattini S
    Vet Comp Oncol; 2021 Sep; 19(3):501-509. PubMed ID: 33624422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
    Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
    Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer.
    Fagerholm R; Hofstetter B; Tommiska J; Aaltonen K; Vrtel R; Syrjäkoski K; Kallioniemi A; Kilpivaara O; Mannermaa A; Kosma VM; Uusitupa M; Eskelinen M; Kataja V; Aittomäki K; von Smitten K; Heikkilä P; Lukas J; Holli K; Bartkova J; Blomqvist C; Bartek J; Nevanlinna H
    Nat Genet; 2008 Jul; 40(7):844-53. PubMed ID: 18511948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.